Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1001\/jama.2009.351<\/electronic-resource-num><urls><related-urls><url>https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/183580\/jpc90002_1148_1154.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.1819-08.2008<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/28\/34\/8462.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1124\/jpet.108.146142<\/electronic-resource-num><urls><related-urls><url>https:\/\/jpet.aspetjournals.org\/content\/jpet\/329\/2\/738.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1111\/bph.14626<\/electronic-resource-num><urls><related-urls><url>https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/bph.14626<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Smoked cocaine self-administration is decreased by modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1038\/sj.npp.1301472<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/1301472.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1016\/j.phrs.2010.04.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>A systematic review of modafinil: Potential clinical uses and mechanisms of action.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.4088\/jcp.v67n0406<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil for the treatment of cocaine dependence.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1016\/j.drugalcdep.2009.04.015<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Approved and investigational uses of modafinil : an evidence-based review.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.2165\/00003495-200868130-00003<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Hypothalamic arousal regions are activated during modafinil-induced wakefulness.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2000<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.20-22-08620.2000<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/20\/22\/8620.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1136\/jnnp.72.2.179<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnnp.bmj.com\/content\/jnnp\/72\/2\/179.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1996<\/year><\/dates><electronic-resource-num>10.1073\/pnas.93.24.14128<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/19505<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1038\/sj.npp.1300457<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/1300457.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1136\/jnnp.2005.065870<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnnp.bmj.com\/content\/jnnp\/76\/12\/1636.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1164\/ajrccm.164.9.2103032<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1016\/0014-2999(90)90591-s<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1992<\/year><\/dates><electronic-resource-num>10.1016\/0006-8993(92)91713-o<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1007\/s002130100916<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/s1474-4422(13)70225-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1126\/science.1164908<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>et al.<\/author><\/authors><\/contributors>Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1001\/jama.2009.351<\/electronic-resource-num><urls><related-urls><url>https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/183580\/jpc90002_1148_1154.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.1819-08.2008<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/28\/34\/8462.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1124\/jpet.108.146142<\/electronic-resource-num><urls><related-urls><url>https:\/\/jpet.aspetjournals.org\/content\/jpet\/329\/2\/738.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1111\/bph.14626<\/electronic-resource-num><urls><related-urls><url>https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/bph.14626<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Smoked cocaine self-administration is decreased by modafinil.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1038\/sj.npp.1301472<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/1301472.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.1016\/j.phrs.2010.04.002<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>A systematic review of modafinil: Potential clinical uses and mechanisms of action.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.4088\/jcp.v67n0406<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil for the treatment of cocaine dependence.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1016\/j.drugalcdep.2009.04.015<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Approved and investigational uses of modafinil : an evidence-based review.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.2165\/00003495-200868130-00003<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Hypothalamic arousal regions are activated during modafinil-induced wakefulness.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2000<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.20-22-08620.2000<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/20\/22\/8620.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1136\/jnnp.72.2.179<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnnp.bmj.com\/content\/jnnp\/72\/2\/179.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1996<\/year><\/dates><electronic-resource-num>10.1073\/pnas.93.24.14128<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/19505<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1038\/sj.npp.1300457<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/1300457.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1136\/jnnp.2005.065870<\/electronic-resource-num><urls><related-urls><url>https:\/\/jnnp.bmj.com\/content\/jnnp\/76\/12\/1636.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1164\/ajrccm.164.9.2103032<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1016\/0014-2999(90)90591-s<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1992<\/year><\/dates><electronic-resource-num>10.1016\/0006-8993(92)91713-o<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.1007\/s002130100916<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/s1474-4422(13)70225-4<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1126\/science.1164908<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"